Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • memento
    Member
    • Nov 2010
    • 49

    Anyone can refer good and not too expensive exome sequencing facility?

    We are looking at a small pilot project, 50-100 exomes (we prefer Illumina based core). Already have some exp with OtoGenetics but their SureSelect capture based option seems pricey. Anyone ? Thanks (not sure if that is the right category to ask for it but....)
    Last edited by memento; 02-15-2012, 09:54 AM.
  • Bukowski
    Senior Member
    • Jan 2010
    • 388

    #2
    Originally posted by memento View Post
    We are looking at a small pilot project, 50-100 exomes (we prefer Illumina based core). Already have some exp with OtoGenetics but their SureSelect capture based option seems pricey. Anyone ? Thanks (not sure if that is the right category to ask for it but....)
    Interrogate key biomarkers with our hybridisation-based FISH, NGS and array products for haematology, solid tumour, cytogenetics and rare disease. Learn more


    Obvious disclaimer applies!

    Comment

    • Gone
      Member
      • Jul 2011
      • 11

      #3
      BGI,you may choose.

      Comment

      • TonyBrooks
        Senior Member
        • Jun 2009
        • 303

        #4
        We've tested a number of exome service providers and are now going to regularly use Axeq.
        We were quoted <£700 per exome using Nimblegen's latest capture.
        We had a number of communication problems and delays with BGI.

        Comment

        • Geneus
          Member
          • Dec 2010
          • 60

          #5
          Originally posted by TonyBrooks View Post
          We had a number of communication problems and delays with BGI.
          What was the matter...wasn't Ryan getting back to you in time?

          Comment

          • ocouronne
            Junior Member
            • Jun 2011
            • 3

            #6
            $999 exome

            We do $999 at the Columbia Genome Center. That includes all reagents, Agilent SureSelect XT Human All Exon v.2 44Mb, Library preparation, 60X depth mapped coverage, 100bp Paired End reads, sequenced on Illumina HiSeq2000 instruments, 2 months data storage, QC, reads mapped to the human reference genome, single nucleotide variants and short insertions/deletions, basic functional annotation of the variants, and summary statistics. Our average turnaround was 55 days last quarter.

            I can send you recommendations from PIs who use our service. We take orders from all over the world.

            We will be happy to answer any questions at [email protected]

            Our FAQ is here:
            The Columbia Genome Center is a specialized environment for conducting high-throughput biomedical research. Our services include: Genome Sequencing & Analysis  High-Throughput Screening 
            Last edited by ocouronne; 02-21-2012, 10:58 AM.

            Comment

            • Gone
              Member
              • Jul 2011
              • 11

              #7
              Originally posted by TonyBrooks View Post
              We've tested a number of exome service providers and are now going to regularly use Axeq.
              We were quoted <£700 per exome using Nimblegen's latest capture.
              We had a number of communication problems and delays with BGI.
              so can you detail the problems?maybe we can give you feedback.

              Comment

              • Geneus
                Member
                • Dec 2010
                • 60

                #8
                Originally posted by Gone View Post
                so can you detail the problems?maybe we can give you feedback.
                If he is in the UK, shouldn't your European subsidiary be addressing these issues? Or do they lack the competence to do so?

                Comment

                • Gone
                  Member
                  • Jul 2011
                  • 11

                  #9
                  Originally posted by Geneus View Post
                  If he is in the UK, shouldn't your European subsidiary be addressing these issues? Or do they lack the competence to do so?
                  Yeah,U're right!BGI-Europe will handle all issues in local region.
                  Anyway,we'll try our best to do any kinds of problems.
                  you know customer forever is God!

                  Comment

                  • Geneus
                    Member
                    • Dec 2010
                    • 60

                    #10
                    Originally posted by Gone View Post
                    Yeah,U're right!BGI-Europe will handle all issues in local region.
                    Anyway,we'll try our best to do any kinds of problems.
                    you know customer forever is God!
                    Yes...that's the way Mr. Mason would want it.

                    Comment

                    • kamichailo
                      Junior Member
                      • Mar 2010
                      • 8

                      #11
                      Best and smartest sequencing facility around is Expression analysis

                      Comment

                      • ECO
                        --Site Admin--
                        • Oct 2007
                        • 1360

                        #12
                        Originally posted by kamichailo View Post
                        Best and smartest sequencing facility around is Expression analysis
                        This should (perhaps obviously) be noted as biased.

                        Comment

                        • Geneus
                          Member
                          • Dec 2010
                          • 60

                          #13
                          Originally posted by ECO View Post
                          This should (perhaps obviously) be noted as biased.
                          LOL...nothing like full disclosure.

                          Comment

                          Latest Articles

                          Collapse

                          • SEQadmin2
                            Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
                            by SEQadmin2


                            Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

                            The systematic characterization of the human proteome has
                            ...
                            07-20-2026, 11:48 AM
                          • SEQadmin2
                            Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
                            by SEQadmin2



                            Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
                            ...
                            07-09-2026, 11:10 AM
                          • SEQadmin2
                            Cancer Drug Resistance: The Lingering Barrier to Rising Survival
                            by SEQadmin2



                            Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

                            There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
                            07-08-2026, 05:17 AM

                          ad_right_rmr

                          Collapse

                          News

                          Collapse

                          Topics Statistics Last Post
                          Started by SEQadmin2, Yesterday, 12:17 PM
                          0 responses
                          13 views
                          0 reactions
                          Last Post SEQadmin2  
                          Started by SEQadmin2, 07-23-2026, 11:41 AM
                          0 responses
                          14 views
                          0 reactions
                          Last Post SEQadmin2  
                          Started by SEQadmin2, 07-20-2026, 11:10 AM
                          0 responses
                          23 views
                          0 reactions
                          Last Post SEQadmin2  
                          Started by SEQadmin2, 07-13-2026, 10:26 AM
                          0 responses
                          37 views
                          0 reactions
                          Last Post SEQadmin2  
                          Working...